Progyny, Inc. (NASDAQ:PGNY) Shares Bought by Landscape Capital Management L.L.C.

Landscape Capital Management L.L.C. increased its holdings in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 109.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 349,614 shares of the company's stock after buying an additional 182,457 shares during the quarter. Progyny comprises approximately 0.6% of Landscape Capital Management L.L.C.'s portfolio, making the stock its 15th biggest holding. Landscape Capital Management L.L.C. owned approximately 0.41% of Progyny worth $6,031,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its position in shares of Progyny by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 8,692,132 shares of the company's stock worth $149,939,000 after acquiring an additional 48,271 shares during the last quarter. Pacer Advisors Inc. boosted its holdings in shares of Progyny by 47.5% in the 4th quarter. Pacer Advisors Inc. now owns 3,676,200 shares of the company's stock valued at $63,414,000 after purchasing an additional 1,183,558 shares during the last quarter. State Street Corp grew its stake in shares of Progyny by 4.5% during the 3rd quarter. State Street Corp now owns 3,113,654 shares of the company's stock valued at $52,185,000 after buying an additional 134,861 shares during the period. River Road Asset Management LLC acquired a new stake in shares of Progyny during the 4th quarter worth $25,529,000. Finally, Fort Washington Investment Advisors Inc. OH raised its position in shares of Progyny by 90.1% in the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 1,467,780 shares of the company's stock worth $25,319,000 after buying an additional 695,740 shares during the period. 94.93% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on PGNY shares. Bank of America boosted their price target on Progyny from $21.00 to $25.00 and gave the company a "buy" rating in a research report on Tuesday, February 11th. Canaccord Genuity Group increased their target price on shares of Progyny from $17.00 to $23.00 and gave the stock a "hold" rating in a research report on Friday, February 28th. JPMorgan Chase & Co. lifted their price target on shares of Progyny from $17.00 to $23.00 and gave the company a "neutral" rating in a research report on Tuesday, January 28th. Finally, BTIG Research upgraded shares of Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price objective for the company in a research note on Monday, March 31st. Eight investment analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $23.64.

Progyny Stock Up 2.1 %

Shares of Progyny stock traded up $0.44 on Wednesday, hitting $21.95. 382,020 shares of the company's stock traded hands, compared to its average volume of 1,715,651. The firm's 50-day moving average is $22.09 and its 200 day moving average is $18.54. The stock has a market cap of $1.87 billion, a P/E ratio of 37.98, a PEG ratio of 2.39 and a beta of 1.33. Progyny, Inc. has a 52-week low of $13.39 and a 52-week high of $36.36.

Progyny Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.